Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Global Pharmaceuticals, Division of Impax Laboratories Inc.)
Welcome to the PulseAid listing for the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate drug offered from Global Pharmaceuticals, Division of Impax Laboratories Inc.. This Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| NON-PROPRIETARY NAME: | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate |
| SUBSTANCE NAME: | DEXTROAMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE SULFATE; AMPHETAMINE ASPARTATE MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2013-12-17 |
| END MARKETING DATE: | 0000-00-00 |
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate from Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| LABELER NAME: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 1.25; 1.25; 1.25; 1.25(mg/1; mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2013-12-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0115-1328_1584c895-bd1a-4dcb-8764-366cb9660310 |
| PRODUCT NDC: | 0115-1328 |
| APPLICATION NUMBER: | NDA021303 |
Other DEXTROAMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE SULFATE; AMPHETAMINE ASPARTATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
